At least the damage at Theranos was confined to professional investors, Reuters writes in this opinion piece. Elizabeth Holmes’ blood-testing outfit touted novel technology and big future sales before its collapse. Holmes, whose trial starts today, blurred the lines between marketing and fraud, and Theranos’ multibillion-dollar private-market valuation dwindled to nothing. Fast forward and Trevor Milton, founder of electric-truck firm Nikola is facing similar charges. Nikola, though, has publicly traded shares. Read more.
Related Posts
Billionaire Lawrence Ho Yau-lung Files for a HK SPAC Listing
Ho is the chief executive of Melco International Development and Melco Resorts & Entertainment, the casino operator.
Op/Ed: Why Buy a SPAC Before It Identifies a Target?
Investing in a SPAC that hasn't yet identified which business it plans to take public might seem highly speculative, a columnist for the Motley Fool writes.
Drained of Cash, Buffalo Bills Owner’s SPAC Closes In on a Deal
Abacus Life is pushing ahead with a merger with Terry Pegula’s East Resources Acquisition despite the fact that 92% of shareholders in the SPAC have swapped their stock for their money back.
ReKTGlobal Reportedly in Talks to Merge With SPAC
The SPAC is discussing raising a PIPE to support the transaction, which is set to value the combined entity at more than $400 million.